<DOC>
	<DOC>NCT03004066</DOC>
	<brief_summary>10 patients with chronic heart failure receiving daptomycin therapy after implantation of a left ventricular heart assist system. Measurement of daptomycin levels in drainage fluids (mediastinal and pleural drainage systems) and in blood samples.</brief_summary>
	<brief_title>Daptomycin Concentration in Drainage Fluid and Blood Samples of ICU Patients</brief_title>
	<detailed_description />
	<mesh_term>Daptomycin</mesh_term>
	<criteria>written consent heart assist device implantation wound drainage daptomycin therapy pregnancy no written consent possible absence of wound drainage allergy to study medication acute rhabdomylosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>